Home > Insider Trading > Filing (0001209191-22-023285)

Filing Details

Accession Number:: 0001209191-22-023285
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-04-05 18:23:50
Reporting Period:: 2022-04-01

Accepted Time:: 2022-04-05 18:23:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1720580	Adicet Bio Inc.	ACET	Pharmaceutical Preparations (2834)	813305277

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1823996	Francesco Galimi	C/O Adicet Bio, Inc. 200 Clarendon Street, Floor 6 Boston MA 02116	Svp & Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-04-01	7,621	$5.97	67,538	No	4	M	Direct
Common Stock	Disposition	2022-04-01	7,621	$21.00	59,917	No	4	S	Direct
Common Stock	Acquisiton	2022-04-04	6,036	$13.27	65,953	No	4	M	Direct
Common Stock	Disposition	2022-04-04	6,036	$21.00	59,917	No	4	S	Direct
Common Stock	Acquisiton	2022-04-04	168	$5.97	60,085	No	4	M	Direct
Common Stock	Disposition	2022-04-04	168	$21.00	59,917	No	4	S	Direct
Common Stock	Acquisiton	2022-04-04	1,775	$16.82	61,692	No	4	M	Direct
Common Stock	Disposition	2022-04-04	1,775	$21.00	59,917	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2022-04-01	7,621	$0.00	7,621	$5.97
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2022-04-04	6,036	$0.00	6,036	$13.27
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2022-04-04	168	$0.00	168	$5.97
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2022-04-04	1,775	$0.00	1,775	$16.82

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
113,820	2029-10-15	No	4	M	Direct
73,964	2031-01-12	No	4	M	Direct
113,652	2029-10-15	No	4	M	Direct
26,625	2031-02-11	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on April 30, 2021.
A total of 128,424 shares subject to an employee stock option were received as described in footnote (3). 25% of the shares vested on September 23, 2020, and 1/36th of the remaining unvested shares vest on each of the next thirty-six (36) monthly anniversaries thereafter, provided that the Reporting Person remains in continuous service as of the applicable vesting date.
Received in exchange for an employee stock option to acquire 1,035,685 shares of common stock of Adicet Bio, Inc., a Delaware corporation ("Old Adicet"), for $0.740 per share in connection with the merger (the "Merger") of Old Adicet with and into Project Oasis Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of resTORbio, Inc., a Delaware corporation ("resTORbio"). On the effective date of the Merger, resTORbio changed its name to "Adicet Bio, Inc."
A total of 80,000 shares subject to an employee stock option were granted on January 13, 2021, with 1/48th of the shares vesting on each of the next forty-eight (48) monthly anniversaries thereafter, provided that the Reporting Person remains in continuous service as of the applicable vesting dates.
A total of 28,400 shares subject to an employee stock option were granted on February 12, 2021, with 1/48th of the shares vesting on each of the next forty-eight (48) monthly anniversaries thereafter, provided that the Reporting Person remains in continuous service as of the applicable vesting dates.